IDEAS home Printed from https://ideas.repec.org/a/plo/pmed00/1002094.html
   My bibliography  Save this article

Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study

Author

Listed:
  • Nita G Forouhi
  • Fumiaki Imamura
  • Stephen J Sharp
  • Albert Koulman
  • Matthias B Schulze
  • Jusheng Zheng
  • Zheng Ye
  • Ivonne Sluijs
  • Marcela Guevara
  • José María Huerta
  • Janine Kröger
  • Laura Yun Wang
  • Keith Summerhill
  • Julian L Griffin
  • Edith J M Feskens
  • Aurélie Affret
  • Pilar Amiano
  • Heiner Boeing
  • Courtney Dow
  • Guy Fagherazzi
  • Paul W Franks
  • Carlos Gonzalez
  • Rudolf Kaaks
  • Timothy J Key
  • Kay Tee Khaw
  • Tilman Kühn
  • Lotte Maxild Mortensen
  • Peter M Nilsson
  • Kim Overvad
  • Valeria Pala
  • Domenico Palli
  • Salvatore Panico
  • J Ramón Quirós
  • Miguel Rodriguez-Barranco
  • Olov Rolandsson
  • Carlotta Sacerdote
  • Augustin Scalbert
  • Nadia Slimani
  • Annemieke M W Spijkerman
  • Anne Tjonneland
  • Maria-Jose Tormo
  • Rosario Tumino
  • Daphne L van der A
  • Yvonne T van der Schouw
  • Claudia Langenberg
  • Elio Riboli
  • Nicholas J Wareham

Abstract

Background: Whether and how n-3 and n-6 polyunsaturated fatty acids (PUFAs) are related to type 2 diabetes (T2D) is debated. Objectively measured plasma PUFAs can help to clarify these associations. Methods and Findings: Plasma phospholipid PUFAs were measured by gas chromatography among 12,132 incident T2D cases and 15,919 subcohort participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct study across eight European countries. Country-specific hazard ratios (HRs) were estimated using Prentice-weighted Cox regression and pooled by random-effects meta-analysis. We also systematically reviewed published prospective studies on circulating PUFAs and T2D risk and pooled the quantitative evidence for comparison with results from EPIC-InterAct. In EPIC-InterAct, among long-chain n-3 PUFAs, α-linolenic acid (ALA) was inversely associated with T2D (HR per standard deviation [SD] 0.93; 95% CI 0.88–0.98), but eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated. Among n-6 PUFAs, linoleic acid (LA) (0.80; 95% CI 0.77–0.83) and eicosadienoic acid (EDA) (0.89; 95% CI 0.85–0.94) were inversely related, and arachidonic acid (AA) was not significantly associated, while significant positive associations were observed with γ-linolenic acid (GLA), dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to 1.46 per SD. These findings from EPIC-InterAct were broadly similar to comparative findings from summary estimates from up to nine studies including between 71 to 2,499 T2D cases. Limitations included potential residual confounding and the inability to distinguish between dietary and metabolic influences on plasma phospholipid PUFAs. Conclusions: These large-scale findings suggest an important inverse association of circulating plant-origin n-3 PUFA (ALA) but no convincing association of marine-derived n3 PUFAs (EPA and DHA) with T2D. Moreover, they highlight that the most abundant n6-PUFA (LA) is inversely associated with T2D. The detection of associations with previously less well-investigated PUFAs points to the importance of considering individual fatty acids rather than focusing on fatty acid class. Using a large European cohort, Nita Forouhi and colleagues investigate the association between the concentration of polyunsaturated fatty acids measured in plasma and risk of developing type 2 diabetes.Why Was This Study Done?: What Did the Researchers Do and Find?: What Do These Findings Mean?:

Suggested Citation

  • Nita G Forouhi & Fumiaki Imamura & Stephen J Sharp & Albert Koulman & Matthias B Schulze & Jusheng Zheng & Zheng Ye & Ivonne Sluijs & Marcela Guevara & José María Huerta & Janine Kröger & Laura Yun Wa, 2016. "Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study," PLOS Medicine, Public Library of Science, vol. 13(7), pages 1-17, July.
  • Handle: RePEc:plo:pmed00:1002094
    DOI: 10.1371/journal.pmed.1002094
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002094
    Download Restriction: no

    File URL: https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002094&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pmed.1002094?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pmed00:1002094. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosmedicine (email available below). General contact details of provider: https://journals.plos.org/plosmedicine/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.